findmyKOL

Aimaz Afrough, MD

Basic profile

Southwestern Medical Center

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyHematologyFocusHematology
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Aimaz Afrough is a Hematology physician affiliated with Southwestern Medical Center. OpenAlex indexes 194 publications with 1,380 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
194publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,380citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
15companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

6201 Harry Hines Blvd
Dallas, TX 753905201

Telephone

214-633-5555

Provider last certified this registry record 1 Sept 2021.

View the NPPES registry record

Industry payments

15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    34.1%
    Thalidomide Analog34.1%
    Lenalidomide50%Revlimid38%Pomalyst12%
    Part D38 patients
  • Dermatology

    18.8%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor18.8%
    Acyclovir100%
    Part D45 patients
  • Metabolism & gastrointestinal

    11.3%
    Serotonin-3 Receptor Antagonist6.5%
    Ondansetron Hcl100%
    Part D30 patients
    Potassium supplement2.7%
    Potassium Chloride100%
    Part D16 patients

    + 1 more class in this area

Where care is delivered (Part B)73.6% facility · 26.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”